4.5 Article

Lack of association of Aspergillus colonization with the development of bronchiolitis obliterans syndrome in lung transplant recipients: An international cohort study

期刊

JOURNAL OF HEART AND LUNG TRANSPLANTATION
卷 38, 期 9, 页码 963-971

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.healun.2019.06.007

关键词

lung transplantation; aspergillus; colonization; risk factors; BOS

向作者/读者索取更多资源

BACKGROUND: Bronchiolitis obliterans syndrome (BOS) is a major limitation in the long-term survival of lung transplant recipients (LTRs). However, the risk factors in the development of BOS remain undetermined. We conducted an international cohort study of LTRs to assess whether Aspergillus colonization with large or small conidia is a risk factor for the development of BOS. METHODS: Consecutive LTRs from January 2005 to December 2008 were evaluated. Rates of BOS and associated risk factors were recorded at 4 years. International Society of Heart and Lung Transplantation criteria were used to define fungal and other infections. A Cox proportional-hazards-model was constructed to assess the association between Aspergillus colonization and the development of BOS controlling for confounders. RESULTS: A total of 747 LTRs were included. The cumulative incidence of BOS at 4 years after transplant was 33% (250 of 747). Additionally, 22% of LTRs experienced Aspergillus colonization after transplantation. Aspergillus colonization with either large (hazard ratio [HR] = 0.6, 95% confidence interval [CI] = 0.3-1.2, p = 0.12) or small conidia (HR = 0.9, 95% CI = 0.6-1.4, p = 0.74) was not associated with the development of BOS. Factors associated with increased risk of development of BOS were the male gender (HR = 1.4, 95% CI = 1.1-1.8, p = 0.02) and episodes of acute rejection (1-2 episodes, HR = 1.5, 95% CI = 1.1-2.1, p = 0.014; 3-4 episodes, HR = 1.6, 95% CI = 1.0-2.6, p = 0.036; >4 episodes, HR = 2.2, 95% CI = 1.1-4.3, p = 0.02), whereas tacrolimus use was associated with reduced risk of BOS (HR = 0.6, 95% CI = 0.5-0.9, p = 0.007). CONCLUSIONS: We conclude from this large multicenter cohort of lung transplant patients, that Aspergillus colonization with large or small conidia did not show an association with the development of BOS. (C) 2019 International Society for Heart and Lung Transplantation. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Cardiac & Cardiovascular Systems

The effect of COVID-19 on transplant function and development of CLAD in lung transplant patients: A multicenter experience

Elizabeth Roosma, Johanna P. Van Gemert, Auke E. S. De Zwart, Coretta C. Van Leer-Buter, Merel E. Hellemons, Elize M. Berg, Bart Luijk, Rogier A. S. Hoek, Diana A. Van Kessel, Onno W. Akkerman, Huib A. M. Kerstjens, Erik A. M. Verschuuren, C. Tji Gan

Summary: This study retrospectively analyzed the impact of COVID-19 on transplant function in LTx patients, showing high mortality in hospitalized patients, decline in lung function 3 months post infection, gradual improvement at 6 months but still lower than pre-infection levels.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2022)

Article Cardiac & Cardiovascular Systems

Reflux Surgery in Lung Transplantation: A Multicenter Retrospective Study

Cynthia L. Green, Brian C. Gulack, Shaf Keshavjee, Lianne G. Singer, Kenneth McCurry, Marie M. Budev, Tammy L. Reece, Anne O. Lidor, Scott M. Palmer, R. Duane Davis

Summary: A multicenter retrospective study found limited benefits of fundoplication for preventing bronchiolitis obliterans syndrome and improving survival compared to reflux disease without surgery after lung transplantation. However, the study had limitations in terms of sample size, follow-up duration, and potential selection bias, highlighting the need for a randomized, prospective study.

ANNALS OF THORACIC SURGERY (2023)

Article Urology & Nephrology

Proton Pump Inhibitor Use, Fatigue, and Health-Related Quality of Life in Kidney Transplant Recipients: Results From the Transplant Lines Biobank and Cohort Study

Tim J. Knobbe, Daan Kremer, Rianne M. Douwes, Michele F. Eisenga, Antonio W. Gomes-Neto, Coby Annema, J. Casper Swarte, Frank Klont, Gerjan Navis, Stefan P. Berger, Stephan J. L. Bakker

Summary: Prior studies have shown that the use of proton pump inhibitors (PPIs) can negatively impact gut microbiota and the absorption of micronutrients, such as iron and magnesium. This study aims to investigate the association between PPI use and fatigue and health-related quality of life (HRQoL) in kidney transplant recipients.

AMERICAN JOURNAL OF KIDNEY DISEASES (2023)

Article Pharmacology & Pharmacy

A Joint Pharmacokinetic Model for the Simultaneous Description of Plasma and Whole Blood Tacrolimus Concentrations in Kidney and Lung Transplant Recipients

Jeroen J. Koomen, Tim R. Knobbe, Tanja Zijp, Daan Kremer, C. Tji Gan, Erik A. M. Verschuuren, Stephan J. L. J. Bakker, Daan J. Touw, Pieter Colin, TransplantLines Investigators

Summary: This study aimed to establish plasma concentration ranges reflecting the currently used target ranges of whole blood tacrolimus concentrations. By developing a pharmacokinetic model and performing simulations, it was found that the whole blood target ranges for kidney and lung transplant recipients corresponded to plasma concentration ranges of 0.06-0.26 ng/mL and 0.10-0.93 ng/mL, respectively.

CLINICAL PHARMACOKINETICS (2023)

Review Immunology

Invasive aspergillosis in liver transplant recipients

Clea Melenotte, Vishukumar Aimanianda, Monica Slavin, Jose Maria Aguado, Darius Armstrong-James, Yee-Chun Chen, Shahid Husain, Christian Van Delden, Faouzi Saliba, Agnes Lefort, Francoise Botterel, Olivier Lortholary

Summary: Invasive aspergillosis is a rare but serious infection in liver transplant recipients, with a high mortality rate. Risk factors before, during, and after transplantation have been identified, and accurate diagnosis requires collaboration between radiology and clinical biology. It is recommended to reduce the dose of tacrolimus and closely monitor blood levels when using certain drugs, and surgery should be considered on a case-by-case basis. Antifungal prophylaxis and environmental measures should be implemented to prevent outbreaks.

TRANSPLANT INFECTIOUS DISEASE (2023)

Article Multidisciplinary Sciences

Post-hoc analysis of the safety and efficacy of isavuconazole in older patients with invasive fungal disease from the VITAL and SECURE studies

Kamal Hamed, Marc Engelhardt, Laura L. Kovanda, Jin Ju Huang, Jean Yan, Jalal A. Aram

Summary: Isavuconazole was found to have a higher rate of adverse events and lower efficacy in patients aged 65 and above with invasive fungal diseases.

SCIENTIFIC REPORTS (2023)

Article Medicine, General & Internal

Increasing Antibody Responses to Five Doses of SARS-CoV-2 mRNA Vaccine in Lung Transplant Patients

Johanna van Gemert, Fleur Steenberg, Coretta van Leer-Buter, Huib Kerstjens, Willie Steenhuis, Onno Akkerman, Erik Verschuuren, Tji Gan

Summary: COVID-19 causes high mortality in LTx patients, so vaccination in this population is crucial. However, the antibody response is impaired after multiple vaccinations. This study aims to investigate the possibility of increasing this response and identify risk factors for non-response.

JOURNAL OF CLINICAL MEDICINE (2023)

Review Microbiology

Phaeohyphomycosis in Solid Organ Transplant Recipients: A Case Series and Narrative Review of the Literature

Davide Lo Porto, Andrea Cona, Francesca Todaro, Elena De Carolis, Francesca Cardinale, Neha Hafeez, Giuseppina Di Martino, Pier Giulio Conaldi, Maurizio Sanguinetti, Paolo Antonio Grossi, Alessandra Mularoni

Summary: Phaeohyphomycosis is a diverse infection caused by pigmented fungi, and solid organ transplant recipients are at increased risk due to immunosuppression. In this study, three successful cases of phaeohyphomycosis in transplant recipients were treated with surgery and antifungal therapy. A literature review revealed a wide range of fungal species, with Alternaria being the most common. Early diagnosis and treatment are crucial in preventing disease dissemination.

JOURNAL OF FUNGI (2023)

Review Microbiology

MicroRNAs in infectious diseases: potential diagnostic biomarkers and therapeutic targets

Muneyoshi Kimura, Sagar Kothari, Wajiha Gohir, Jose F. Camargo, Shahid Husain

Summary: MicroRNAs (miRNAs) play a crucial role in post-transcriptional gene expression regulation, disease pathogenesis, and immune response. They are explored as diagnostic biomarkers and therapeutic targets in clinical settings.

CLINICAL MICROBIOLOGY REVIEWS (2023)

Editorial Material Cardiac & Cardiovascular Systems

Predicting outcomes in lung transplantation: From tea leaves to ChatGPT

Dmitry Rozenberg, Lianne G. Singer

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2023)

Letter Oncology

Genomic profiling of post-transplant lymphoproliferative disorders using cell-free DNA

Nick Veltmaat, Yujie Zhong, Filipe Montes de Jesus, Geok Wee Tan, Johanna A. A. Bult, Martijn M. Terpstra, Pim G. N. J. Mutsaers, Wendy B. C. Stevens, Rogier Mous, Joost S. P. Vermaat, Martine E. D. Chamuleau, Walter Noordzij, Erik A. M. Verschuuren, Klaas Kok, Joost L. Kluiver, Arjan Diepstra, Wouter J. Plattel, Anke Van den Berg, Marcel Nijland

Summary: The study investigates the use of cfDNA for genomic profiling of PTLD, and explores its potential as a screening tool. Analysis showed that 41% of patients had EBV-positive tumors and 76% had stage IV disease. The study provides important insights into the genetic variations and EBV infection in PTLD.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2023)

Article Immunology

Favorable experience of transplant strategy including liver grafts from COVID-19 donors: One-year follow-up results

Silvia Martini, Margherita Saracco, Donatella Cocchis, Fabrizia Pittaluga, Bruna Lavezzo, Francesca Barisone, Luigi Chiusa, Antonio Amoroso, Massimo Cardillo, Paolo A. Grossi, Renato Romagnoli

Summary: This study evaluated the medium-term outcomes of liver transplant recipients from COVID-19 donors and found favorable results in terms of patient survival. However, there was a higher risk of hepatic artery thrombosis compared to recipients from COVID-19-negative donors.

TRANSPLANT INFECTIOUS DISEASE (2023)

Review Immunology

Screening for Latent Tuberculosis Infection in Solid Organ Transplant Recipients to Predict Active Disease: A Systematic Review and Meta-Analysis of Diagnostic Studies

Dafna Yahav, Melissa R. Gitman, Ili Margalit, Tomer Avni, Mariska M. G. Leeflang, Shahid Husain

Summary: This meta-analysis examined the predictive value of TST and IGRA for active TB in solid organ transplantation patients. The results showed that both tests have a high negative predictive value but a low positive predictive value.

OPEN FORUM INFECTIOUS DISEASES (2023)

Article Multidisciplinary Sciences

Health-related quality of life is linked to the gut microbiome in kidney transplant recipients

J. Casper Swarte, Tim J. Knobbe, Johannes R. Bjork, Ranko Gacesa, Lianne M. Nieuwenhuis, Shuyan Zhang, Arnau Vich Vila, Daan Kremer, Rianne M. Douwes, Adrian Post, Evelien E. Quint, Robert A. Pol, Bernadien H. Jansen, Martin H. de Borst, Vincent E. de Meijer, Hans Blokzijl, Stefan P. Berger, Eleonora A. M. Festen, Alexandra Zhernakova, Jingyuan Fu, Hermie J. M. Harmsen, Stephan J. L. Bakker, Rinse K. Weersma

Summary: This study investigates the association between the gut microbiome and Health-Related Quality of Life (HRQoL) in kidney transplant recipients. The results show that multiple bacterial species are associated with lower HRQoL in this population, and physical and mental HRQoL explain a significant part of the variance in the gut microbiome. Additionally, metabolic and neuroactive pathways are also associated with lower HRQoL, suggesting potential modifiable factors to improve HRQoL.

NATURE COMMUNICATIONS (2023)

Article Surgery

Three Decades Single Center Experience of Airway Complications After Lung Transplantation

R. van Pel, C. T. Gan, W. van der Bij, E. A. M. Verschuuren, J. P. A. van Gemert, C. van de Wauwer, M. E. Erasmus, D. J. Slebos

Summary: Post lung transplantation airway complications, especially stenosis, significantly affect survival. Risk factors for the development of airway complications are unclear.

TRANSPLANT INTERNATIONAL (2023)

暂无数据